Clinical Trials Logo

Filter by:
NCT ID: NCT00620022 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Start date: April 2008
Phase: Phase 3
Study type: Interventional

This study compared the effect of indacaterol (300 μg once daily [od]) on exercise endurance with that of placebo in patients with moderate to severe chronic obstructive pulmonary disease.

NCT ID: NCT00619957 Completed - Other Osteoporosis Clinical Trials

Efficacy and Safety of Risedronate Therapy Administered 35 mg Once A Week in Men With Osteoporosis

Start date: June 2002
Phase: Phase 3
Study type: Interventional

Two year study to determine the safety and efficacy of weekly 35 mg Risedronate doses in men with osteoporosis followed by a two year follow-up study.

NCT ID: NCT00619788 Completed - Clinical trials for Peripheral Arterial Occlusive Disease

FeMoropopliteal AngioSculpt™ SCoring BallOon CaTheter Study

MASCOT
Start date: March 2008
Phase: Phase 2/Phase 3
Study type: Interventional

This investigation is designed to demonstrate the efficacy and safety of the 4.0-5.0mm AngioSculpt Scoring Balloon Catheter (AngioScore, Inc.) for femoropopliteal use in a controlled clinical investigation. The scoring balloon is a semi-compliant balloon encircled by 3 spiral struts with a nitinol scoring element, which theoretically provides targeted scoring of lesions, by concentrating the dilation force thus minimizing barotrauma, elastic recoil and uncontrolled dissection. This may improve the outcome of the intervention and reduce the number of stents required.

NCT ID: NCT00618930 Completed - Clinical trials for Colorectal Cleansing Prior Operation

Moviprep® Versus Fleet Phospho-Soda® (Golden Standard): A Study That Compared Two Laxatives on Patients Undergoing Colo-Rectal Cleansing Prior to an Abdominal Operation

Start date: February 2008
Phase: Phase 4
Study type: Interventional

The patients are assigned by randomisation on one of the two laxatives. After cleansing they have to fill in an evaluation form to report their findings and difficulties. Also the surgeon will be asked to fill in a score-form to report all details concerning the bowel preparation.

NCT ID: NCT00617604 Completed - Clinical trials for De Novo Kidney Transplantation

A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients

Start date: December 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether alefacept is effective and well tolerated when used with a combination of tacrolimus, mycophenolate mofetil and steroids versus a combination therapy of placebo, tacrolimus and steroids in the prevention of kidney transplant rejection.

NCT ID: NCT00617175 Completed - Heart Disease Clinical Trials

Avoid DeliVering TherApies for Non-sustained Arrhythmias in ICD PatiEnts III

ADVANCEIII
Start date: March 2008
Phase: Phase 4
Study type: Interventional

To demonstrate a reduction in the number of ventricular therapies (ATP and Shocks) delivered for treating spontaneous arrhythmia episodes with a fast cycle length (CL≤ 320ms) as a consequence of self-termination and better arrhythmia discrimination due to a greater number of R-R intervals necessary to detect ventricular events.

NCT ID: NCT00616135 Completed - Breast Neoplasms Clinical Trials

Study of Autologous Fat Enhanced w/ Regenerative Cells Transplanted to Reconstruct Breast Deformities After Lumpectomy

RESTORE-2
Start date: June 2008
Phase: Phase 4
Study type: Interventional

A post-marketing study evaluating the transplantation of autologous fat augmented with Adipose Derived Regenerative Cells (ADRCs), in patients with functional and cosmetic breast deformities post segmental mastectomy or quadrantectomy (lumpectomy).

NCT ID: NCT00616057 Completed - Obesity Clinical Trials

Evaluation of Fructans Supplementation on Parameters of Metabolic Syndrome

FRUCTOB
Start date: February 2008
Phase: N/A
Study type: Interventional

Obesity is constantly increasing, causing an important risk to develop diseases such as heart disease, diabetes,... Some recent studies have shown that obese people present modifications of colon microflora and a low-grade inflammation. In our laboratory, we have demonstrated that the intake of fructans lessens dietary intake, body weight gain, adipose tissue accumulation and steatosis in rodents. These effects lead to an improvement of insulin resistance and hyperglycemia in diabetic rats and mice. Fructans are also able to restore the microflora disturbed by a high fat diet and to prevent endotoxemia. Moreover, studies have shown that fructans intake promotes satiety (Cani et al, Diabetes 2007) and or decreases fat mass (Abrams et al, Journal of Pediatrics 2007) in healthy human. An intervention study in obese patients is thus needed to study the effects of fructans in the target population.

NCT ID: NCT00615940 Completed - Clinical trials for Metastatic Breast Cancer

Combination of Oral WX-671 Plus Capecitabine vs. Capecitabine Monotherapy in First-line Her2-negative Metastatic Breast Cancer

Start date: July 2008
Phase: Phase 2
Study type: Interventional

This randomized, double-blind, placebo controlled phase II trial is studying how well capecitabine works when given in combination with WX-671 or when given alone in treating patients receiving first-line therapy for her2negative metastatic breast cancer.

NCT ID: NCT00615225 Completed - Brain Death Clinical Trials

Brain Death: Inflammatory Response, Apoptosis, and Endotoxin Tolerance

Start date: January 2000
Phase: N/A
Study type: Observational

We hypothesized that brain death is associated with an early systemic inflammatory response, possibly combined with activation of apoptotic cell death, two events that may contribute to induce rapid organ dysfunction. In this study of brain-dead donors and controls, we assayed plasma cytokines and soluble factors, investigated plasma endotoxin levels as a triggering factor for inflammation, measured ex vivo cytokine production by blood leukocytes to determine whether immunosuppression occurred after brain death, and examined skeletal muscle biopsies to look for evidence of inflammation and increased apoptosis in peripheral tissue.